There is a newer version of the record available.

Published March 28, 2021 | Version 1
Dataset Open

Cerebral expression of metabotropic glutamate receptor subtype 5 in idiopathic autism spectrum disorder and fragile X syndrome.: A pilot study

Creators

  • 1. Johns Hopkins University
  • 2. Institute for Neurodegenerative Disorders
  • 3. Denali Therapeutics, Inc.
  • 4. Kennedy Krieger Institute
  • 5. Washington University in Saint Louis

Description

Table S1. Concomitant medications of participants with fragile X syndrome (FXS) from the Institute for Neurodegenerative Disorders

Table S2. Demographic and clinical characteristics of participants from the Institute for Neurodegenerative Disorders (IND)

Table S3. Demographic and clinical data of participants from Johns Hopkins University (JHU)

Table S4. Genetic and psychological assessments of participants from the Institute for Neurodegenerative Disorders

Table S5. Genetic and psychological assessments of participants with fragile X syndrome and family members from Johns Hopkins University.

Table S6. Positron emission tomography (PET) data and analyses for participants from the Institute for Neurodegenerative Disorders

Table S7. Positron emission tomography (PET) data and analysis of participants from Johns Hopkins University

The authors thank Flora Tassone, Ph.D., Department of Biochemistry and Molecular Medicine, School of Medicine,  UC Davis Health, Sacramento, California, for providing genetic and protein data about participants.

Notes

This research was made possible by a Radiology BRidge/Development Funding Initiative to STimulate and Advance Research (RAD BriteStar Bridge) Award from the Johns Hopkins University School of Medicine, Baltimore, Maryland, to JRB; the Intellectual & Developmental Disabilities Research Center (U54 HD079123), Kennedy Krieger Institute, Johns Hopkins Medical Institutions. Baltimore, Maryland, to JRB; and the Johns Hopkins Institute for Clinical and Translational Research (ICTR), Johns Hopkins University School of Medicine, Baltimore, Maryland, to JRB, which is funded in part by Grant Number UL1 TR003098 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS or NIH.

Files

Legends Cerebral.pdf

Files (180.8 kB)

Name Size Download all
md5:3807dde2aea7f3a17b67cbd3b120256d
11.4 kB Download
md5:9c0cc28d3cb22882798788e925c793c7
60.2 kB Preview Download
md5:2444f6cd36f41e212c819d79970db63e
11.4 kB Download
md5:65547f1b36504c6adeb022848ee2f633
19.8 kB Download
md5:4d457f9d2b9738269e8a06e9205c6a89
14.4 kB Download
md5:18698e1ba30b076369e6748c65e19ede
11.2 kB Download
md5:08f52b5d998358d384d9deb0e418bbbc
16.2 kB Download
md5:dd6fe27bfdbd7f1730783a5732bb7fc5
36.2 kB Download

Additional details

Related works

Is supplemented by
Journal article: 10.3390/ijms22062863 (DOI)

References

  • Benedict RHB et al. (1998) The Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability. Clin. Neuropsychol. 12: 43-55.
  • Brandt J et al. (1998) Hopkins Verbal Learning Test-Revised (TM) [HVLT-R(TM)]. Par, Inc., Lutz, Florida, USA
  • Cambridge Cognition Ltd. Cambridge Neuropsychological Test Automated Battery (CANTAB). Cambridge Cognition Ltd., Cambridge, UK, 2020. Available online: www.cambridgecognition.com (accessed 26 September 2020)
  • Deb S et al. (2007) Dementia Screening Questionnaire for Individuals with Intellectual Disabilities. Br J Psychiatry 190: 440-444. DOI: 10.1192/bjp.bp.106.024984. PMID: 17470960
  • Fatemi SH, et al. Metabotropic glutamate receptor 5 tracer [18F]-FPEB displays increased binding potential in postcentral gyrus and cerebellum of male individuals with autism: a pilot PET study. Cerebellum Ataxias 2018, 5, 3. doi: 10.1186/s40673-018-0082-1. PMID: 29449954
  • Folstein MF et al. (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189-198. DOI: 10.1016/0022-3956(75)09226-6. PMID: 1202204
  • Ichise M, et al. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J. Cereb. Blood Flow Metab. 2002, 22 1271-1281. doi: 10.1097/01.WCB.0000038000.34930.4E. PMID: 1236866
  • Innis, R.B.; Cunninghamm V.J.; Delforge, J.; Fujita, M.; Gjedde, A.; Gunn, R.N.; Holden, J.; Houle, S.; Huang, S.C.; Ichise, M.; Iida, H.; Ito, H.; Kimura, Y.; Koeppe, R.A.; Knudsen, G.M.; Knuuti, J.; Lammertsma, A.A.; Laruelle, M.; Logan, J.; Maguire, R.P.; Mintun, M.A.; Morris, E.D.; Parsey, R.; Price, J.C.; Slifstein, M.; Sossi, V.; Suhara, T.; Votaw, J.R.; Wong, D.F.; Carson, R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27, 1533-1539. doi: 10.1038/sj.jcbfm.9600493. Epub 2007 May 9. PMID: 17519979.
  • Logan J et al., 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16, 834-840. doi: 10.1097;00004647-199609000-00008. PMID: 8784228
  • Logan J et al., 2011.The use of alternative forms of graphical analysis to balance bias and precision in PET images. J. Cereb. Blood Flow Metab. 2011, 31, 535-546. doi:10.1038/jcbfm.2010.123. PMID: 20808318.
  • Lord C et al. (2012) Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2). Western Psychological Services (WPS), Torrance, California, USA
  • Roid GH. Stanford-Binet Intelligence Scales, 5th Edition (SB-5). Western Psychological Services (WPS), Torrance, California, USA, 2003
  • Shapiro AM et al. (1999) Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin. Neuropsychol. 13: 348-358. DOI: 10.1076/clin.13.3.348.1749. PMID: 10726605
  • Sparrow SS et al. (2020) Vineland Adaptive Behavior Scales, 3rd Edition (Vineland-3). Pearson, San Antonio, Texas, USA
  • Sullivan J et al. Test-retest evaluation of [F-18] FPEB, a PET tracer for the mGluR5 receptors in humans. J. Cereb. Blood Flow Metab. 2012, 32 (supplement 1), S122-S123 [abstract]
  • Sullivan JM et al. Kinetic analysis of the metabotropic glutamate subtype 5 tracer [18F]FPEB in bolus and bolus plus-constant-infusion studies in humans. J. Cereb. Blood Flow Metab. 2013, 33, 532-541. doi: 10.1038/jcbfm.2012.195. PMID: 23250105.
  • Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, UK. Statistical Parametric Mapping (SPM). 2020. Available online: http://www.fil.ion.ucl.ac.uk/spm/
  • Wienhard K et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J. Comput. Assist. Tomogr. 1994, 18, 110-118. PMID: 8282858
  • Wong, D.F.; Waterhouse, R.; Kuwabara, H.; Kim, J.; Brašić, J.R.; Chamroonrat, W.; Stabins, M.; Holt, D.P.; Dannals, R.F.; Hamill, T.G.; Mozley, P.D. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. J. Nucl. Med. 2013, 54, 388-396. doi: 10.2967/jnumed.112.107995. Epub 2013 Feb 12. PMID: 23404089